Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) reported second-quarter 2026 revenue of $20.2 million, down sharply from a year earlier, while gross profit came in at $18.4 million. The company’s operating loss was $58.5 million, reflecting continued pressure on profitability.
Net loss attributable to common shareholders widened to $93.4 million, and diluted loss per share was $0.75. Cash used in operating activities totaled $44.3 million, while capital spending on property and equipment was $2.6 million.
On the balance sheet, cash and cash equivalents stood at $84.5 million, and total liabilities were $569.8 million. Shares fell 2.88% after the market close following the release.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Ginkgo Bioworks Holdings, Inc. Insider Trading Activity
Ginkgo Bioworks Holdings, Inc. insiders have traded $DNA stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $DNA stock by insiders over the last 6 months:
- JASON R KELLY (See remarks) has made 0 purchases and 2 sales selling 206,782 shares for an estimated $1,374,493.
- RESHMA P. SHETTY (See remarks) has made 0 purchases and 3 sales selling 150,998 shares for an estimated $977,560.
- BARRY CANTON has made 0 purchases and 3 sales selling 150,998 shares for an estimated $977,560.
- STEVEN P. COEN (See remarks) has made 0 purchases and 5 sales selling 35,262 shares for an estimated $228,605.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Ginkgo Bioworks Holdings, Inc. Hedge Fund Activity
We have seen 77 institutional investors add shares of Ginkgo Bioworks Holdings, Inc. stock to their portfolio, and 56 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ERSTE ASSET MANAGEMENT GMBH added 589,211 shares (+30.3%) to their portfolio in Q2 2026, for an estimated $5,839,081
- MILLENNIUM MANAGEMENT LLC added 439,056 shares (+897.8%) to their portfolio in Q1 2026, for an estimated $2,691,413
- MORGAN STANLEY removed 306,487 shares (-40.0%) from their portfolio in Q1 2026, for an estimated $1,878,765
- TUDOR INVESTMENT CORP ET AL added 270,701 shares (+139.6%) to their portfolio in Q1 2026, for an estimated $1,659,397
- ALLIANZ ASSET MANAGEMENT GMBH added 250,728 shares (+55.7%) to their portfolio in Q1 2026, for an estimated $1,536,962
- LINGOTTO INVESTMENT MANAGEMENT LLP removed 250,282 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,534,228
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 227,987 shares (-99.7%) from their portfolio in Q1 2026, for an estimated $1,397,560
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Ginkgo Bioworks Holdings, Inc. Government Contracts
We have seen $25,913,376 of award payments to $DNA over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TRAVELER-BASED GENOMIC SURVEILLANCE PROGRAM: $20,999,983
- TEST SURGE AND DATA SHARING MULTIPLE AWARD IDIQ: $1,272,072
- DARPA ICE CONTROL FOR COLD ENVIRONMENTS (ICE): $441,445
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
